Sign in Subscribe
Diseases

Breakthrough in Foot-and-Mouth Disease Vaccine Research

Strategic Insights

— 1 min read

Research from Madrid, Spain, has reported significant findings in developing a safer and more effective vaccine against Foot-and-Mouth Disease Virus (FMDV). The study aims to address the limitations of traditional inactivated virus vaccines by exploring subunit vaccine strategies, such as those based on synthetic peptides. The research, published in npj Vaccines, demonstrates the potential of a single low-dose peptide vaccine to induce a robust neutralizing response in swine, providing full protection against FMDV.

Key Takeaways:

  • Researchers from Centro de Investigacion en Sanidad Animal (CISA-INIA) in Madrid, Spain, have developed a novel peptide vaccine strategy against Foot-and-Mouth Disease Virus (FMDV).
  • The vaccine combines synthetic peptides into a modular dendrimer platform, named BT-TB, which induces a fast and robust neutralizing response in swine.
  • A single low dose of this multiepitopic vaccine confers full protection against FMDV, showing a promising application as an emergency vaccine.
  • The vaccine is designed to meet the requirements of a Differentiation-Inducing Vaccine (DIVA), allowing for the distinction between vaccinated and infected animals.
  • The research highlights the potential of subunit vaccine strategies in addressing the limitations of traditional inactivated virus vaccines against FMDV.
  • The development of this vaccine has significant implications for the livestock sector, providing a safer and more effective solution for controlling FMDV outbreaks.
  • The study's authors, led by Elisa Torres, emphasize the need for further research to optimize the vaccine's performance and address potential challenges in its implementation.

Statistics:

  • A single low dose of the peptide vaccine induces a robust neutralizing response in swine, providing full protection against FMDV.
  • The vaccine confers a fast and robust neutralizing response, covering a broad antigenic spectrum.
  • The study included a dimeric version of the preceding construct (BT-TB) that harbors up to six immunologically relevant epitopes.
  • The vaccine meets the requirements of a Differentiation-Inducing Vaccine (DIVA), allowing for the distinction between vaccinated and infected animals.
  • The study was published in npj Vaccines, a peer-reviewed journal from Nature Portfolio.

Sources:

  • NewsRx. "Findings in Foot and Mouth Disease Virus Reported from Elisa Torres and Co-Researchers (Single dose of foot-and-mouth disease peptide vaccine fully protects swine and achieves intraserotype crossed neutralization)." Life Science Weekly. October 21, 2025; p 1403.
  • Torres, E., et al. "Single dose of foot-and-mouth disease peptide vaccine fully protects swine and achieves intraserotype crossed neutralization." npj Vaccines, 2025;10(1):216.

Read more